Global Lung Cancer Therapeutics Market Size, Share, Trends, Growth, Company Profiles, Demand, Analysis, Research, Report, and Forecast 2015-2019 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global Lung Cancer Therapeutics Market Size, Share, Trends, Growth, Company Profiles, Demand, Analysis, Research, Report, and Forecast 2015-2019

Description:

Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Get access to detailed report at: – PowerPoint PPT presentation

Number of Views:25

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Lung Cancer Therapeutics Market Size, Share, Trends, Growth, Company Profiles, Demand, Analysis, Research, Report, and Forecast 2015-2019


1
Global Lung Cancer Therapeutics Market 2015-2019
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2015 -
2019
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_researchbeam.com
2
Report overview
Research Beam adds "Global Lung Cancer
Therapeutics Market 2015-2019". The report on the
Global Lung Cancer Therapeutics Industry provides
a clearer view on market Trends and Growth
factors of the Global Lung Cancer Therapeutics
Market 2015-2019. Cancer occurs when, after
undergoing cell transformation, normal cells grow
and multiply without control. Lung cancer is a
common cause of mortality and morbidity in both
developed and developing countries. Non-small
cell lung cancer is the commonest type of lung
cancer and forms almost 85-90 percent of the
total cases diagnosed. It grows and spreads
slowly. Smoking is considered as a major cause of
lung cancer, though lung cancer also occurs in
non-smokers. Non-small cell lung cancer is of
three types squamous cell (epidermoid)
carcinoma, adenocarcinoma, and large cell
(undifferentiated) carcinoma. Small cell lung
cancers form roughly 10-15 percent of all the
diagnosed cases of lung cancer. There are two
types of small cell lung cancer small cell
carcinoma and combined small cell carcinoma. It
can be classified into two stages limited-stage
small cell lung cancer and extensive-stage small
cell lung cancer. Small cell lung cancer cannot
be cured using current therapies available in the
market. Some of the common symptoms associated
with lung cancer are chest pain, persistent
cough, blood in sputum, fatigue, loss of
appetite, weight loss, shortness of breath, and
wheezing. Both small cell lung cancer and
non-small cell lung cancer are recurrent in
nature, which are difficult to cure. Get access
to detailed report at http//www.researchbeam.com
/global-lung-cancer-therapeutics-2015-2019-market

3
Report overview
TechNavio's analysts forecast the Global Lung
Cancer Therapeutics market to grow at a CAGR of
3.83 percent over the period 2014-2019. Covered
in this Report This report covers the present
scenario and the growth prospects of the Global
Lung Cancer Therapeutics market for the period
2015-2019. To calculate the market size, the
report considers revenue generated from sales of
various drugs used in the treatment of non-small
cell lung cancer and small cell lung cancer. The
Global Lung Cancer Therapeutics market is
segmented based on the type of molecule used for
the treatment of lung cancer, which include
Biologics Small molecules In addition, the
market is also segmented based on the route of
administration followed for the treatment of lung
cancer, which include Oral
Parenteral TechNavio's report, Global Lung Cancer
Therapeutics Market 2015-2019, has been prepared
based on an in-depth market analysis with inputs
from industry experts. The report covers the
Americas, and the EMEA and APAC regions it also
covers the Global Lung Cancer Therapeutics market
landscape and its growth prospects in the coming
years. The report also includes a discussion of
the key vendors operating in this market.

4
Report overview
Key Regions Americas APAC EMEA Key
Vendors AstraZeneca Celgene Eli Lilly F.
Hoffmann-La Roche Pfizer Other Prominent
Vendors Abbvie Aetna Agennix Amgen
Boehringer Ingelheim Celldex Eisai Enquire
about report _at_ http//www.researchbeam.com/global
-lung-cancer-therapeutics-2015-2019-market/enquire
-about-report

5
Table of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Product
Profiles 05. Market Research Methodology 06.
Introduction 07. Disease Overview 08. Market
Landscape 09. Market Segmentation by Disease
Type 10. Market Segmentation by Molecule Type 11.
Market Segmentation by Route of
Administration 12. Geographical Segmentation 13.
Buying Criteria 14. Market Growth Drivers 15.
Drivers and their Impact 16. Market
Challenges 17. Impact of Drivers and
Challenges 18. Market Trends 19. Trends and their
Impact 20. Vendor Landscape 21. Pipeline
Portfolio 22. Key Vendor Analysis 23. Other
Reports in this Series

6
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/global-lung-cancer-the
rapeutics-2015-2019-market
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_researchbeam.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
Stay With Us
About PowerShow.com